Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-25

Clinical Trial Update: Neurokinin Receptor Antagonist Associated to Ondansetron in PONV [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a neurokinin receptor antagonist in combination with ondansetron for postoperative nausea and vomiting. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED